FDA Generics Research Forges Ahead After Agency’s Bupropion Mea Culpa

In an unusual essay in the New England Journal of Medicine, CDER Director Janet Woodcock acknowledges that “the conservative approach did not provide the right conclusion regarding therapeutic equivalence in a timely manner.”